1st longer term tirzepatide study (3 years)
Nov 14, 2024•45 min•Ep. 101
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis.
Learn:
- If people lose weight and keep it off with tirzepatide
- How many people regain weight after stopping the medicine
- Long-term side effects
- If semaglutide helps with osteoarthritis
Click here to read the tirzepatide study
Click here to read the semaglutide study
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
For the best experience, listen in Metacast app for iOS or Android